Literature DB >> 19508970

Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases.

T Furuichi, H Kayserili, S Hiraoka, G Nishimura, H Ohashi, Y Alanay, J C Lerena, A D Aslanger, H Koseki, D H Cohn, A Superti-Furga, S Unger, S Ikegawa.   

Abstract

BACKGROUND: Schneckenbecken dysplasia (SBD) is an autosomal recessive lethal skeletal dysplasia that is classified into the severe spondylodysplastic dysplasias (SSDD) group in the international nosology for skeletal dysplasias. The radiological hallmark of SBD is the snail-like configuration of the hypoplastic iliac bone. SLC35D1 (solute carrier-35D1) is a nucleotide-sugar transporter involved in proteoglycan synthesis. Recently, based on human and mouse genetic studies, we showed that loss-of-function mutations of the SLC35D1 gene (SLC35D1) cause SBD. OBJECT: To explore further the range of SLC35D1 mutations in SBD and elucidate whether SLC35D1 mutations cause other skeletal dysplasias that belong to the SSDD group. METHODS AND
RESULTS: We searched for SLC35D1 mutations in five families with SBD and 15 patients with other SSDD group diseases, including achodrogenesis type 1A, spondylometaphyseal dysplasia Sedaghatian type and fibrochondrogenesis. We identified four novel mutations, c.319C>T (p.R107X), IVS4+3A>G, a 4959-bp deletion causing the removal of exon 7 (p.R178fsX15), and c.193A>C (p. T65P), in three SBD families. Exon trapping assay showed IVS4+3A>G caused skipping of exon 4 and a frameshift (p.L109fsX18). Yeast complementation assay showed the T65P mutant protein lost the transporter activity of nucleotide sugars. Therefore, all these mutations result in loss of function. No SLC35D1 mutations were identified in all patients with other SSDD group diseases.
CONCLUSION: Our findings suggest that SLC35D1 loss-of-function mutations result consistently in SBD and are exclusive to SBD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508970      PMCID: PMC4144354          DOI: 10.1136/jmg.2008.065201

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  Schneckenbecken dysplasia, radiology, and histology.

Authors:  P G Nikkels; R H Stigter; I E Knol; H J van der Harten
Journal:  Pediatr Radiol       Date:  2001-01

2.  Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity.

Authors:  M Muraoka; M Kawakita; N Ishida
Journal:  FEBS Lett       Date:  2001-04-20       Impact factor: 4.124

Review 3.  Achondrogenesis type I: delineation of further heterogeneity and identification of two distinct subgroups.

Authors:  Z Borochowitz; R Lachman; G E Adomian; G Spear; K Jones; D L Rimoin
Journal:  J Pediatr       Date:  1988-01       Impact factor: 4.406

4.  A distinct lethal neonatal chondrodysplasia with snail-like pelvis: Schneckenbecken dysplasia.

Authors:  Z Borochowitz; K L Jones; R Silbey; G Adomian; R Lachman; D L Rimoin
Journal:  Am J Med Genet       Date:  1986-09

5.  Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human.

Authors:  Shuichi Hiraoka; Tatsuya Furuichi; Gen Nishimura; Shunichi Shibata; Masaki Yanagishita; David L Rimoin; Andrea Superti-Furga; Peter G Nikkels; Minako Ogawa; Kayoko Katsuyama; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Nobuhiro Ishida; Kyoichi Isono; Yutaka Sanai; Daniel H Cohn; Haruhiko Koseki; Shiro Ikegawa
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

6.  Case report 693: Schneckenbecken dysplasia.

Authors:  A Giedion; K Biedermann; J Briner; R Soler; M Spycher
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

Review 7.  Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35).

Authors:  Nobuhiro Ishida; Masao Kawakita
Journal:  Pflugers Arch       Date:  2003-05-21       Impact factor: 3.657

8.  Fibrochondrogenesis: lethal, autosomal recessive chondrodysplasia with distinctive cartilage histopathology.

Authors:  C B Whitley; L O Langer; J Ophoven; E F Gilbert; C H Gonzalez; M Mammel; M Coleman; S Rosemberg; C J Rodriques; R Sibley
Journal:  Am J Med Genet       Date:  1984-10

9.  Congenital lethal metaphyseal chondrodysplasia: a newly recognized complex autosomal recessive disorder.

Authors:  M R Sedaghatian
Journal:  Am J Med Genet       Date:  1980

10.  Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.

Authors:  A Rossi; A Superti-Furga
Journal:  Hum Mutat       Date:  2001-03       Impact factor: 4.878

View more
  16 in total

1.  Inhibition of Golgi apparatus glycosylation causes endoplasmic reticulum stress and decreased protein synthesis.

Authors:  Yu-Xin Xu; Li Liu; Carolina E Caffaro; Carlos B Hirschberg
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

2.  A second locus for Schneckenbecken dysplasia identified by a mutation in the gene encoding inositol polyphosphate phosphatase-like 1 (INPPL1).

Authors:  Hane Lee; Lisette Nevarez; Ralph S Lachman; William R Wilcox; Deborah Krakow; Daniel H Cohn
Journal:  Am J Med Genet A       Date:  2015-05-22       Impact factor: 2.802

3.  Conserved Glu-47 and Lys-50 residues are critical for UDP-N-acetylglucosamine/UMP antiport activity of the mouse Golgi-associated transporter Slc35a3.

Authors:  M Agustina Toscanini; M Belén Favarolo; F Luis Gonzalez Flecha; Berit Ebert; Carsten Rautengarten; Luis M Bredeston
Journal:  J Biol Chem       Date:  2019-05-22       Impact factor: 5.157

Review 4.  INPPL1 gene mutations in opsismodysplasia.

Authors:  Anaïs Fradet; Jamie Fitzgerald
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

Review 5.  The role of nucleotide sugar transporters in development of eukaryotes.

Authors:  Li Liu; Yu-Xin Xu; Carlos B Hirschberg
Journal:  Semin Cell Dev Biol       Date:  2010-02-06       Impact factor: 7.727

6.  Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia.

Authors:  Cori Feist; Paul Holden; Jamie Fitzgerald
Journal:  Clin Dysmorphol       Date:  2016-10       Impact factor: 0.816

Review 7.  Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests.

Authors:  Florin Sasarman; Catalina Maftei; Philippe M Campeau; Catherine Brunel-Guitton; Grant A Mitchell; Pierre Allard
Journal:  J Inherit Metab Dis       Date:  2015-12-21       Impact factor: 4.982

8.  Dysosteosclerosis is also caused by TNFRSF11A mutation.

Authors:  Long Guo; Nursel H Elcioglu; Ozge K Karalar; Mert O Topkar; Zheng Wang; Yuma Sakamoto; Naomichi Matsumoto; Noriko Miyake; Gen Nishimura; Shiro Ikegawa
Journal:  J Hum Genet       Date:  2018-03-22       Impact factor: 3.172

9.  A functional splice variant of the human Golgi CMP-sialic acid transporter.

Authors:  Roberta Salinas-Marín; Rosella Mollicone; Iván Martínez-Duncker
Journal:  Glycoconj J       Date:  2016-07-07       Impact factor: 2.916

Review 10.  Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis.

Authors:  Johanne Dubail; Valérie Cormier-Daire
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.